Intravenous Injection of Muse Cells as a Potential Therapeutic Approach for Epidermolysis Bullosa - PubMed

Affiliations

• PMID: 32540249
• DOI: 10.1016/j.jid.2020.05.092

Free article

Review

Intravenous Injection of Muse Cells as a Potential Therapeutic Approach for Epidermolysis Bullosa

Yasuyuki Fujita et al. J Invest Dermatol. 2021 Jan.

Free article

Similar articles

• Epidermolysis bullosa pruriginosa showing good response to low-dose thalidomide - a report of two cases.

  Ranugha PS, Mohanan S, Chandrashekar L, Basu D, Thappa DM, Rajesh NG. Ranugha PS, et al. Dermatol Ther. 2014 Jan-Feb;27(1):60-3. doi: 10.1111/dth.12047. Epub 2013 Apr 2. Dermatol Ther. 2014. PMID: 24502315

• [Epidermolysis bullosa atrophicans gravis. Report of a therapeutic trial with dapsone].

  Krähe J, Galal O, Kordass U, Bornemann P. Krähe J, et al. Monatsschr Kinderheilkd. 1988 Mar;136(3):140-2. Monatsschr Kinderheilkd. 1988. PMID: 3374498 German.

• Thymosin β4: potential to treat epidermolysis bullosa and other severe dermal injuries.

  Yang WS, Kang S, Sung J, Kleinman HK. Yang WS, et al. Eur J Dermatol. 2019 Oct 1;29(5):459-467. doi: 10.1684/ejd.2019.3642. Eur J Dermatol. 2019. PMID: 31649007 Review.

Cited by

• Effects of human Muse cells on bladder inflammation, overactivity, and nociception in a chemically induced Hunner-type interstitial cystitis-like rat model.

  Furuta A, Kuroda Y, Yamamoto T, Egawa S, Dezawa M, Yoshimura N. Furuta A, et al. Int Urogynecol J. 2022 May;33(5):1293-1301. doi: 10.1007/s00192-022-05166-w. Epub 2022 Mar 25. Int Urogynecol J. 2022. PMID: 35333929

• Exploring SSEA3 as an emerging biomarker for assessing the regenerative potential of dental pulp-derived stem cells.

  Shirakawa J, Ntege EH, Takemura M, Miyamoto S, Kawano T, Sampei C, Kawabata H, Nakamura H, Sunami H, Hayata T, Shimizu Y. Shirakawa J, et al. Regen Ther. 2024 May 25;26:71-79. doi: 10.1016/j.reth.2024.05.004. eCollection 2024 Jun. Regen Ther. 2024. PMID: 38828011 Free PMC article.

• Therapeutic benefit of Muse cells in a mouse model of amyotrophic lateral sclerosis.

  Yamashita T, Kushida Y, Wakao S, Tadokoro K, Nomura E, Omote Y, Takemoto M, Hishikawa N, Ohta Y, Dezawa M, Abe K. Yamashita T, et al. Sci Rep. 2020 Oct 13;10(1):17102. doi: 10.1038/s41598-020-74216-4. Sci Rep. 2020. PMID: 33051552 Free PMC article.

• Endogenous reparative pluripotent Muse cells with a unique immune privilege system: Hint at a new strategy for controlling acute and chronic inflammation.

  Kuroda Y, Oguma Y, Hall K, Dezawa M. Kuroda Y, et al. Front Pharmacol. 2022 Oct 19;13:1027961. doi: 10.3389/fphar.2022.1027961. eCollection 2022. Front Pharmacol. 2022. PMID: 36339573 Free PMC article. Review.

• Treatment of Epidermolysis Bullosa and Future Directions: A Review.

  Danescu S, Negrutiu M, Has C. Danescu S, et al. Dermatol Ther (Heidelb). 2024 Aug;14(8):2059-2075. doi: 10.1007/s13555-024-01227-8. Epub 2024 Aug 2. Dermatol Ther (Heidelb). 2024. PMID: 39090514 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database
  • scite Smart Citations